MasterControl, a leading provider of quality and manufacturing software solutions for life sciences and regulated industries, has announc...
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample...
Expanded treatment in community settings will reduce patient burden Option to redose patients granted in both Ntrust-1 and Ntrust-2 studies Rheumatoi...
Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new state-of –the-art ...
Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care. Illumina (NASDAQ: ILMN) and...
Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare ...
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple sclerosis...
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-...
OncoC4 Inc., a late clinical stage biopharmaceutical company, announced first participant's dosing following the clearance of the Investigational New Dru...
DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam"...
Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement with JW...
Innovaccer Inc., a leading healthcare AI company, and Infinia Technologies, a next-generation digital transformation company and a subsidiary of Sirius I...
Nxera Pharma Co., Ltd. announces that it has achieved a second development milestone under its multi-target collaboration and license agreement with Eli ...
Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program ...
© 2026 Biopharma Boardroom. All Rights Reserved.
